Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
Condition(s):Non-small Cell Lung Cancer; Vomiting; Nausea; EmesisLast Updated:April 3, 2015Unknown status
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer; Vomiting; Nausea; EmesisLast Updated:April 3, 2015Unknown status
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:June 7, 2018Terminated
Condition(s):Chemotherapy Induced Nausea and Vomiting Pediatric Cancer PatientsLast Updated:February 9, 2022Not yet recruiting
Condition(s):Chemotherapy Induced Nausea and Vomiting; Pediatric Cancer PatientsLast Updated:May 10, 2021Not yet recruiting
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:September 23, 2021Completed
Condition(s):Pediatric CancerLast Updated:September 2, 2021Not yet recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:November 19, 2020Recruiting
Condition(s):Solid Tumor Patients Receiving High Emetic Risk Multi-day ChemotherapyLast Updated:September 2, 2020Not yet recruiting
Condition(s):Postoperative NauseaLast Updated:February 11, 2021Active, not recruiting
Condition(s):Gastrointestinal Cancer; Nausea Post ChemotherapyLast Updated:April 8, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.